Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?
Silvestro L, Nasti G, Ottaiano A, Montano M, Casaretti R, Avallone A, Berretta M, Romano C, Cassata A, Tafuto S, Iaffaioli RV. Silvestro L, et al. Among authors: tafuto s. Anticancer Agents Med Chem. 2013 Nov;13(9):1364-70. doi: 10.2174/18715206113136660356. Anticancer Agents Med Chem. 2013. PMID: 24102272 Review.
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Comella P, Gambardella A, Farris A, Maiorino L, Natale D, Massidda B, Casaretti R, Tafuto S, Lorusso V, Leo S; Southern Italy Cooperative Oncology Group. Comella P, et al. Among authors: tafuto s. Crit Rev Oncol Hematol. 2005 Feb;53(2):133-9. doi: 10.1016/j.critrevonc.2004.10.008. Crit Rev Oncol Hematol. 2005. PMID: 15661564 Clinical Trial.
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.
Comella P, Massidda B, Palmeri S, Farris A, Lucia LD, Natale D, Maiorino L, Tafuto S, Cataldis GD, Casaretti R. Comella P, et al. Among authors: tafuto s. Cancer Chemother Pharmacol. 2005 Nov;56(5):481-6. doi: 10.1007/s00280-005-1003-6. Epub 2005 May 18. Cancer Chemother Pharmacol. 2005. PMID: 15902461 Clinical Trial.
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
Comella P, Natale D, Farris A, Gambardella A, Maiorino L, Massidda B, Casaretti R, Tafuto S, Lorusso V, Leo S, Cannone M. Comella P, et al. Among authors: tafuto s. Cancer. 2005 Jul 15;104(2):282-9. doi: 10.1002/cncr.21167. Cancer. 2005. PMID: 15948167 Free article. Clinical Trial.
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Comella P, Massidda B, Filippelli G, Farris A, Natale D, Barberis G, Maiorino L, Palmeri S, Cannone M, Condemi G; Southern Italy Cooperative Oncology Group. Comella P, et al. J Cancer Res Clin Oncol. 2009 Feb;135(2):217-26. doi: 10.1007/s00432-008-0454-7. Epub 2008 Aug 22. J Cancer Res Clin Oncol. 2009. PMID: 18719941 Clinical Trial.
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Gridelli C, Gallo C, Morabito A, Iaffaioli RV, Favaretto A, Isa L, Barbera S, Gamucci T, Ceribelli A, Filipazzi V, Maione P, Rossi A, Barletta E, Signoriello S, De Maio E, Piccirillo MC, Di Maio M, Rocco G, Vecchione A, Perrone F; G-STEP Investigators. Gridelli C, et al. J Thorac Oncol. 2012 Jan;7(1):233-42. doi: 10.1097/JTO.0b013e318233d6c2. J Thorac Oncol. 2012. PMID: 22031232 Free article. Clinical Trial.
102 results